Multiple vascular contractile agonists generate their responses by activating Rho-kinase pathway including endothelin-1 [39], angiotensin-II [40], and arachidonic acid metabolites (thromboxane A2) [41], in common, these important mediators are elevated in obesity [42–45]. The gene discussed is EDN1; the disease is obesity disorder.